Invesco Ltd. I Teos Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 84,355 shares of ITOS stock, worth $648,689. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,355

Previous 84,586 0.27%

Holding current value

$648,689

Previous $1.26 Million 31.39%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.09 - $17.97 $2,330 - $4,151	-231 Reduced 0.27%	84,355 $861,000
Q2 2024 Aug 13, 2024	BUY	$10.33 - $18.09 $278 - $488	27 Added 0.03%	84,586 $1.26 Million
Q1 2024 May 14, 2024	BUY	$9.89 - $13.64 $470,032 - $648,254	47,526 Added 128.33%	84,559 $1.15 Million
Q4 2023 Feb 12, 2024	SELL	$8.57 - $11.06 $1.46 Million - $1.88 Million	-170,132 Reduced 82.12%	37,033 $405,000
Q3 2023 Nov 13, 2023	SELL	$10.95 - $14.6 $89,811 - $119,749	-8,202 Reduced 3.81%	207,165 $2.27 Million
Q2 2023 Aug 11, 2023	SELL	$12.93 - $18.05 $4.83 Million - $6.74 Million	-373,194 Reduced 63.41%	215,367 $2.85 Million
Q1 2023 May 12, 2023	SELL	$13.02 - $22.62 $260,907 - $453,282	-20,039 Reduced 3.29%	588,561 $8.01 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $1.13 Million - $1.37 Million	63,421 Added 11.63%	608,600 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $717,011 - $1.05 Million	38,549 Added 7.61%	545,179 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $6.32 Million - $13.4 Million	381,607 Added 305.23%	506,630 $10.4 Million
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $2.49 Million - $3.7 Million	78,056 Added 166.19%	125,023 $4.02 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $1.03 Million - $1.88 Million	39,223 Added 506.5%	46,967 $2.19 Million
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $185,159 - $229,067	7,744 New	7,744 $209,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $274M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account